Home » Targeted Drug Slows Thyroid Cancer
Targeted Drug Slows Thyroid Cancer
In a small, placebo-controlled study, vandetanib (Caprelsa), a kinase inhibitor, delayed progression of the most common type of thyroid cancer, French researchers reported.
MedPage Today
MedPage Today
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May